Lexicon Pharmaceuticals (NASDAQ:LXRX) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a report issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on the stock. Needham & Company LLC reiterated a “hold” rating […]
Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a report issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on the stock. Needham & Company LLC reiterated a “hold” rating […]
